Theratechnologies to Present at the Cantor Fitzgerald Global Healthcare Conference on September 29, 2021
Theratechnologies (NASDAQ: THTX) announced that CEO Paul Levesque will participate in a fireside chat at the Cantor Fitzgerald Global Healthcare Conference on September 29, 2021, at 10:00 a.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Theratechnologies (NASDAQ: THTX) announced that CEO Paul Levesque will participate in a fireside chat at the Cantor Fitzgerald Global Healthcare Conference on September 29, 2021, at 10:00 a.m. ET. A live webcast of the event will be available on the company’s investor relations website, with an archive accessible for 90 days post-event.
Theratechnologies focuses on developing innovative therapies to meet unmet medical needs. More details can be found on their website.
Details
News Market Reaction – THTX
The recorded move for THTX in the trading session of this news was -0.28%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MONTREAL, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Paul Levesque, President and Chief Executive Officer, will participate in a fireside chat at the Cantor Fitzgerald Global Healthcare Conference on September 29, 2021 at 10:00 a.m. ET.
A live webcast of the event can be accessed through the investor relations section of Theratechnologies’ website under ‘Events’ or via the virtual conference link. An archive will also be available for 90 days following the event.
About Theratechnologies
Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company's website at www.theratech.com, on SEDAR at www.sedar.com and on EDGAR at www.sec.gov.
For investor and media inquiries:
Leah Gibson
Senior Director, Investor Relations
communications@theratech.com
617-356-1009
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.